Pasteurized Akkermansia muciniphila Muc^T for weight loss maintenance in people with overweight and obesity: a controlled randomized trial

Pasteurized Akkermansia muciniphila has been shown to improve metabolic health and the maintenance of weight loss in individuals with overweight and obesity.

According to a randomized trial published in Nature Medicine on May 13, 2026, the administration of this gut bacterium helped participants sustain weight loss following a low-energy diet.

The research indicates that the benefits of the intervention were particularly significant for individuals who had lower initial levels of Akkermansia in their gut microbiome.

The trial focused on the intersection of dietary changes and microbiome modulation, specifically utilizing a low-energy diet in combination with the pasteurized bacterium.

In addition to assisting with weight loss maintenance, the study found that the treatment improved overall metabolic health for the participants involved.

The use of a pasteurized version of A. Muciniphila is a central component of the study’s approach. Pasteurization is a heat-treatment process used to deactivate microorganisms.

By applying this process to the bacterium, researchers were able to evaluate its efficacy as a tool for managing metabolic health in populations struggling with obesity.

The findings suggest that A. Muciniphila could serve as a potential target for future weight management strategies, especially when tailored to an individual’s existing gut bacteria levels.

This development points toward a more personalized approach to metabolic health, where the baseline composition of a person’s microbiome determines the effectiveness of specific bacterial interventions.